Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Gross Margin (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 16 years of Gross Margin data on record, last reported at 38.37% in Q2 2025.

  • For Q2 2025, Gross Margin fell 722.0% year-over-year to 38.37%; the TTM value through May 2025 reached 31.27%, down 136.0%, while the annual FY2025 figure was 31.27%, 136.0% down from the prior year.
  • Gross Margin reached 38.37% in Q2 2025 per LFCR's latest filing, up from 28.01% in the prior quarter.
  • Across five years, Gross Margin topped out at 117.99% in Q2 2022 and bottomed at 11.12% in Q3 2023.
  • Average Gross Margin over 5 years is 35.3%, with a median of 30.11% recorded in 2025.
  • Peak YoY movement for Gross Margin: skyrocketed 8553bps in 2022, then plummeted -9302bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 57.17% in 2021, then tumbled by -55bps to 25.97% in 2022, then rose by 27bps to 33.02% in 2023, then increased by 3bps to 34.04% in 2024, then grew by 13bps to 38.37% in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Margin were 38.37% in Q2 2025, 28.01% in Q1 2025, and 34.04% in Q4 2024.